Mortalidad por enfermedad de Alzheimer en México de 1980 a 2014

Rosa, Alfredo de Jesús Celis-de la; Cabrera-Pivaral, Carlos Enrique; Báez-Báez, María Guadalupe Laura; Celis-Orozco, Alfredo; Gabriel-Ortíz, Genaro; Zavala-González, Marco Antonio

doi:10.24875/gmm.18003361

Cited by 3 publications

(6 citation statements)

References 3 publications

Supporting

Mentioning

Contrasting

Unclassified

Order By: Relevance

“…Taylor et al, for their part, reported that the mortality rate in females is higher than in male, and the mortality rate increases with age, especially in the group above 75 years old [10]. A study in Mexico stated that there is an increase in Alzheimer's mortality trends in males and females over the age of 40 [8]. A study by Moschetti et al reported that the age-standardized mortality rates increased from 45.3 in 1999 to 50.0 in 2008 [19].…”

Section: Discussionmentioning

confidence: 99%

“…All over the world, scientific and technological developments in the field of medicine, prevention of diseases, provision of early diagnosis and treatment, as well as the development of preventive health services, are among the principal reasons for the increase in the elderly population [5]. In European Union countries [6], France [7], Mexico [8], Brazil [9], as well as in Alzheimer's related mortality studies conducted in America [10], it is stated that the age-standardized mortality rates have increased over the years; in the 75 years age group, these increases are even higher. According to a study conducted in China, it was stated that there is a slight decrease in mortality rates in recent years [3].…”

Section: Introductionmentioning

confidence: 99%

See 1 more Smart Citation

Alzheimer's Disease Mortality Trends in Turkey, 2009-2018

Doğan

2021

Acta Medica Alanya

View full text Add to dashboard Cite

Amaç: Dünyada, yaşam koşullarındaki iyileşmeler, bakım ve sağlık hizmetlerindeki gelişmelerin bir sonucu olarak nüfus yaşlanmaktadır. Alzheimer hastalığına ait en önemli risk faktörü yaştır ve nüfusun yaşlanmasıyla birlikte hem prevelans hem de mortalite oranları artmaktadır. Çalışmanın amacı, 2009-2018 yılları arasında Alzheimer hastalığına bağlı mortalite oranlarının cinsiyet ve yaş gruplarına göre yıllar itibari ile nasıl bir eğilim gösterdiğini belirlemektir. Metot: Alzheimer hastalığı ile ilgili veriler Türkiye İstatistik Kurumu ölüm veri tabanından elde edildi. Yaşa göre standartlaştırılmış ölüm oranları, Dünya Standart Popülasyonuna göre doğrudan yöntem kullanılarak hesaplandı. Yıllık yüzde değişim, ortalama yıllık yüzde değişimini ve %95 güven aralıklarının (GA) tahmini için Joinpoint Regresyon Analizi'nden yararlanıldı. Bulgular: Gözlemlenen dönemde Alzheimer hastalığından dolayı 95,000'den fazla kişi hayatını kaybetmiştir (37,961 erkek ve 57,936 kadın). Joinpoint regresyon analizi, yaşa göre standartlaştırılmış Alzheimer ölüm oranı, 2009'dan 2015'e kadar her yıl %13.3'lük anlamlı bir artış (%95 GA: 10.6;16.2; p<0.001) ve 2015'den dönem sonuna kadar ise %0,5'lik anlamlı olmayan bir azalış (%95 GA: 5,3;4,7; p=0,82) göstermiştir. Cinsiyete göre değerlendirildiğinde ise hem kadınlarda hem de erkeklerde ölüm oranları 2009'dan 2015'e kadar önemli bir artış göstermiştir. Daha sonra dönem sonuna kadar erkeklerde önemsiz bir düşüş, kadınlarda ise önemsiz bir artış olmuştur. Sonuç: Bu çalışmadan elde edilen bulgular tıpta, sosyal hizmetlerde, kamu politikasında ve halk sağlığında şimdiki ve gelecekteki sağlık planlaması ve politikalar geliştirme hakkında bilgi verebilir.

show abstract

Section: Discussionmentioning

confidence: 99%

Section: Introductionmentioning

confidence: 99%

Alzheimer's Disease Mortality Trends in Turkey, 2009-2018

Doğan

2021

Acta Medica Alanya

View full text Add to dashboard Cite

show abstract

“…A general increase in life expectancy has caused an aging population and a resulting rise in the incidence of diseases that were less prevalent a few years ago such as neurodegenerative disorders [1]. At present, Alzheimer's disease (AD) is the most common type of dementia [2][3][4][5][6][7][8][9][10][11][12][13][14][15][16][17]. It was first described in 1907 [9] by the German physician Alois Alzheimer [1], who diagnosed it in a 51-year-old woman.…”

Section: Introductionmentioning

confidence: 99%

“…More specifically, it is calculated that 10% of the population aged ≥65 years and 50% of that ≥85 years will suffer from AD [18]. Aging, therefore, greatly increases the risk of AD [6,9,21], which by now has become a social and public health issue [1].…”

Section: Introductionmentioning

confidence: 99%

See 1 more Smart Citation

Prevalence of Comorbidities in Individuals Diagnosed and Undiagnosed with Alzheimer’s Disease in León, Spain and a Proposal for Contingency Procedures to Follow in the Case of Emergencies Involving People with Alzheimer’s Disease

Tortajada-Soler

Sánchez-Valdeón

Blanco-Nistal

et al. 2020

IJERPH

View full text Add to dashboard Cite

Background: Alzheimer’s disease (AD) which is the most common type of dementia is characterized by mental or cognitive disorders. People suffering with this condition find it inherently difficult to communicate and describe symptoms. As a consequence, both detection and treatment of comorbidities associated with Alzheimer’s disease are substantially impaired. Equally, action protocols in the case of emergencies must be clearly formulated and stated. Methods: We performed a bibliography search followed by an observational and cross-sectional study involving a thorough review of medical records. A group of AD patients was compared with a control group. Each group consisted of 100 people and were all León residents aged ≥65 years. Results: The following comorbidities were found to be associated with AD: cataracts, urinary incontinence, osteoarthritis, hearing loss, osteoporosis, and personality disorders. The most frequent comorbidities in the control group were the following: eye strain, stroke, vertigo, as well as circulatory and respiratory disorders. Comorbidities with a similar incidence in both groups included type 2 diabetes mellitus, glaucoma, depression, obesity, arthritis, and anxiety. We also reviewed emergency procedures employed in the case of an emergency involving an AD patient. Conclusions: Some comorbidities were present in both the AD and control groups, while others were found in the AD group and not in the control group, and vice versa.

show abstract

Intervención cognitiva mediante videojuegos en adulto mayor con Alzheimer: Estudio de caso.

Landa

Bello

García

et al. 2023

dilemas

View full text Add to dashboard Cite

La Organización Mundial de la Salud define Alzheimer como una enfermedad neurodegenerativa caracterizada por un deterioro progresivo de la memoria y la función cognitiva, por lo que se requiere una intervención cognitiva como parte del tratamiento no farmacológico. El objetivo fue evaluar el impacto de la estimulación cognitiva basado en el uso de videojuegos en un adulto mayor con etapa temprana de Alzheimer. Se utilizó MoCA por su alta precisión diagnóstica para el Alzheimer. La puntuación inicial obtenida fue de 7 puntos y al finalizar el plan terapéutico fue de 17 puntos, reflejando mayor dominio en áreas cognitivas como la memoria, capacidad viso-espacial y atención. En conclusión, es posible que las intervenciones con videojuegos ayuden a mantener las funciones cognitivas.

show abstract

Mortalidad por enfermedad de Alzheimer en México de 1980 a 2014

Cited by 3 publications

References 3 publications

Alzheimer's Disease Mortality Trends in Turkey, 2009-2018

Alzheimer's Disease Mortality Trends in Turkey, 2009-2018

Prevalence of Comorbidities in Individuals Diagnosed and Undiagnosed with Alzheimer’s Disease in León, Spain and a Proposal for Contingency Procedures to Follow in the Case of Emergencies Involving People with Alzheimer’s Disease

Intervención cognitiva mediante videojuegos en adulto mayor con Alzheimer: Estudio de caso.

Contact Info

Product

Resources

About